Literature DB >> 33653371

Osteosarcoma: a review of current and future therapeutic approaches.

Xin Zhao1, Qirui Wu2, Xiuqing Gong3, Jinfeng Liu2, Yujie Ma2.   

Abstract

Osteosarcoma (OS) is the most common primary bone malignancy that affects children and young adults. OS is characterized by a high degree of malignancy, strong invasiveness, rapid disease progression, and extremely high mortality rate; it is considered as a serious threat to the human health globally. The incidence of OS is common in the metaphysis of long tubular bones, but rare in the spine, pelvis, and sacrum areas; moreover, majority of the OS patients present with only a single lesion. OS has a bimodal distribution pattern, that is, its incidence peaks in the second decade of life and in late adulthood. We examine historical and current literature to present a succinct review of OS. In this review, we have discussed the types, clinical diagnosis, and modern and future treatment methods of OS. The purpose of this article is to inspire new ideas to develop more effective therapeutic options.

Entities:  

Keywords:  Diagnosis; Osteosarcoma; Staging; Treatment

Mesh:

Substances:

Year:  2021        PMID: 33653371      PMCID: PMC7923306          DOI: 10.1186/s12938-021-00860-0

Source DB:  PubMed          Journal:  Biomed Eng Online        ISSN: 1475-925X            Impact factor:   2.819


  94 in total

Review 1.  Osteosarcoma: anatomic and histologic variants.

Authors:  Michael J Klein; Gene P Siegal
Journal:  Am J Clin Pathol       Date:  2006-04       Impact factor: 2.493

Review 2.  An update on chemotherapy for osteosarcoma.

Authors:  Stefano Ferrari; Massimo Serra
Journal:  Expert Opin Pharmacother       Date:  2015-10-29       Impact factor: 3.889

Review 3.  Understanding osteosarcomas.

Authors:  Emily Simpson; Heather L Brown
Journal:  JAAPA       Date:  2018-08

4.  Limb-sparing surgery for high-grade malignant tumors of the proximal tibia. Surgical technique and a method of extensor mechanism reconstruction.

Authors:  M M Malawer; K A McHale
Journal:  Clin Orthop Relat Res       Date:  1989-02       Impact factor: 4.176

Review 5.  Radiological appearances of appendicular osteosarcoma: a comprehensive pictorial review.

Authors:  S Suresh; A Saifuddin
Journal:  Clin Radiol       Date:  2007-01-30       Impact factor: 2.350

6.  Multimodality treatment of osteosarcoma: radiation in a high-risk cohort.

Authors:  Anita Mahajan; Shiao Y Woo; David G Kornguth; Dennis Hughes; Winston Huh; Eric L Chang; Cynthia E Herzog; Christopher E Pelloski; Pete Anderson
Journal:  Pediatr Blood Cancer       Date:  2008-05       Impact factor: 3.167

Review 7.  Osteosarcoma: Current Treatment and a Collaborative Pathway to Success.

Authors:  Michael S Isakoff; Stefan S Bielack; Paul Meltzer; Richard Gorlick
Journal:  J Clin Oncol       Date:  2015-08-24       Impact factor: 44.544

Review 8.  Osteosarcoma: current status of immunotherapy and future trends (Review).

Authors:  Kanji Mori; Françoise Rédini; François Gouin; Bertrand Cherrier; Dominique Heymann
Journal:  Oncol Rep       Date:  2006-03       Impact factor: 3.906

Review 9.  WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition.

Authors:  Vickie Y Jo; Christopher D M Fletcher
Journal:  Pathology       Date:  2014-02       Impact factor: 5.306

10.  Stereotactic body radiotherapy for metastatic and recurrent ewing sarcoma and osteosarcoma.

Authors:  Lindsay C Brown; Rachael A Lester; Michael P Grams; Michael G Haddock; Kenneth R Olivier; Carola A S Arndt; Peter S Rose; Nadia N Laack
Journal:  Sarcoma       Date:  2014-12-09
View more
  28 in total

Review 1.  Management of bone diseases: looking at scaffold-based strategies for drug delivery.

Authors:  Myriam Bordone; Ana Bettencourt
Journal:  Drug Deliv Transl Res       Date:  2022-07-11       Impact factor: 5.671

2.  Slow release curcumin-containing soy protein nanoparticles as anticancer agents for osteosarcoma: synthesis and characterization.

Authors:  Hadi Zare-Zardini; Hossein Soltaninejad; Adel Ghorani-Azam; Reza Nafisi-Moghadam; Navid Haddadzadegan; Mojtaba Ansari; Seyed Houssein Saeed-Banadaki; Mohammad Reza Sobhan; Sima Mozafari; Mahlagha Zahedi
Journal:  Prog Biomater       Date:  2022-07-25

3.  New Borane-Protected Derivatives of α-Aminophosphonous Acid as Anti-Osteosarcoma Agents: ADME Analysis and Molecular Modeling, In Vitro Studies on Anti-Cancer Activities, and NEP Inhibition as a Possible Mechanism of Anti-Proliferative Activity.

Authors:  Magdalena Mizerska-Kowalska; Sylwia Sowa; Beata Donarska; Wojciech Płaziński; Adrianna Sławińska-Brych; Aleksandra Tomasik; Anna Ziarkowska; Krzysztof Z Łączkowski; Barbara Zdzisińska
Journal:  Int J Mol Sci       Date:  2022-06-16       Impact factor: 6.208

4.  Meta-analysis of the prognosis after surgical treatment of osteosarcoma complicated by pathologic fracture.

Authors:  Wei Zhong; Ziyi Wu; Yuhao Yuan; Wei Luo
Journal:  Am J Transl Res       Date:  2022-04-15       Impact factor: 3.940

5.  Efficacy of ifosfamide combined with liposome doxorubicin on osteosarcoma and its effects on serum IL-10, TNF-α, and IFN-γ in patients with osteosarcoma.

Authors:  Guilin Huang; Sha Hua; Heming Liu; Haizhen Zhou; Xiujin Chen; Zhichou Wang; Wenxing Yu
Journal:  Am J Transl Res       Date:  2022-02-15       Impact factor: 4.060

6.  Determination of VEGF165 using impedimetric aptasensor based on cyclohexanehexone-melem covalent-organic framework.

Authors:  Jiangnan Li; Yang Liu; Changbao Wang; Qiaojuan Jia; Geyi Zhang; Xiaoyu Huang; Nan Zhou; Zhihong Zhang
Journal:  Mikrochim Acta       Date:  2021-05-28       Impact factor: 5.833

7.  Niclosamide Suppresses Migration and Invasion of Human Osteosarcoma Cells by Repressing TGFBI Expression via the ERK Signaling Pathway.

Authors:  Liang-Tsai Yeh; Chiao-Wen Lin; Ko-Hsiu Lu; Yi-Hsien Hsieh; Chao-Bin Yeh; Shun-Fa Yang; Jia-Sin Yang
Journal:  Int J Mol Sci       Date:  2022-01-01       Impact factor: 5.923

8.  The role of SPI1-TYROBP-FCER1G network in oncogenesis and prognosis of osteosarcoma, and its association with immune infiltration.

Authors:  Jiahua Li; Hui Shi; Zhanyuan Yuan; Zhiheng Wu; Haohao Li; Yuelong Liu; Ming Lu; Ming Lu
Journal:  BMC Cancer       Date:  2022-01-25       Impact factor: 4.430

Review 9.  The Emerging Role of MicroRNAs in Bone Diseases and Their Therapeutic Potential.

Authors:  Luis Alberto Bravo Vázquez; Mariana Yunuen Moreno Becerril; Erick Octavio Mora Hernández; Gabriela García de León Carmona; María Emilia Aguirre Padilla; Samik Chakraborty; Anindya Bandyopadhyay; Sujay Paul
Journal:  Molecules       Date:  2021-12-30       Impact factor: 4.411

10.  Pharmacodynamics and pharmacokinetics of PLGA-based doxorubicin-loaded implants for tumor therapy.

Authors:  Peng He; Shenglin Xu; Zehao Guo; Peng Yuan; Yulei Liu; Yu Chen; Tiantian Zhang; Yukang Que; Yong Hu
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.